Questions Concerning the Clinical Translation of Cell-Based Interventions under an Innovation Pathway

Research output: Contribution to journalArticle

Abstract

Stem cell-based innovation is one pathway to clinical translation that stands in contrast to clinical research and medical treatment. After reviewing recently issued guidelines for responsible innovation, this article examines the potential benefits and harms of using this pathway as well as practical barriers and conceptual concerns regarding it.

Original languageEnglish (US)
Pages (from-to)945-950
Number of pages6
JournalJournal of Law, Medicine and Ethics
Volume40
Issue number4
DOIs
StatePublished - Dec 1 2012

    Fingerprint

ASJC Scopus subject areas

  • Issues, ethics and legal aspects
  • Health Policy

Cite this